DNV Overseas Impex Private Limited

DNV Overseas Impex Private Limited - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U51909DL2004PTC129354 Incorporated 23 September 2004 ROC Delhi HQ New Delhi, Delhi, India
Merged Private Limited Company pharma
Revenue · FY 2018
₹61.67 Cr
▲ 74% YoY
Net profit · FY 2018
₹6.4 Cr
Net margin 10.4%
EBITDA · FY 2018
₹10.11 Cr
EBITDA margin 16.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹63.29 Lakh
Issued & subscribed
Satisfied charges
₹7.09 Cr
No open charges
Company age
22 yrs
Est. 2004
Employees · EPFO
397
Provident fund records

About DNV Overseas Impex Private Limited

Data last updated:

DNV Overseas Impex Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 2004.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2004PTC129354. The company has 2 GST registrations on record, none of which is active.

The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹63.29 Lakh. It was led by directors including Deepak Malhotra and Abhiruchi Mengi.

Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Tf – 1 Ansal Utility Commercial Complex Paschim Vihar, New Delhi, Delhi, India – 110063.

As per the financials filed for FY 2018, the company reported a revenue of ₹61.67 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹6.4 Cr (net margin 10.4%) and EBITDA of ₹10.11 Cr (EBITDA margin 16.4%). Revenue has grown at a compounded annual rate (CAGR) of 191% over three years.

The company had about 397 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: DNV Overseas Impex. As per MCA filings, the company had satisfied charges of ₹7.09 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.48 Cr; the latest was in November 2017. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Shamshree Lifesciences Limited with revenue of ₹62.27 Cr.

The last known website on record is dnvoverseas.com.

Company details

CIN U51909DL2004PTC129354
Registration Number 129354
Incorporation Date 23 September 2004
ROC Delhi
Listing Status Unlisted
Company Status Amalgamated

Contact details

DNV Overseas Impex Private Limited's registered office is in New Delhi, Delhi. Its website is dnvoverseas.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Tf – 1 Ansal Utility Commercial Complex Paschim Vihar, New Delhi, Delhi, India – 110063
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of DNV Overseas Impex Private Limited, buy the company report.

Comprehensive company report
DNV Overseas Impex Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

DNV Overseas Impex operates one associated brand: DNV Overseas Impex. Each brand links to its own profile.

BrandDescriptionWebsite
Contract manufacturer of a range of solid and liquid dosage formsdnvoverseas.com

Business activity

The main business activity of DNV Overseas Impex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of DNV Overseas Impex Private Limited, buy the company report.

Financials of DNV Overseas Impex Private Limited

FY 2018 filings available

DNV Overseas Impex Private Limited reported revenue of ₹61.67 Cr (up 74% YoY) for FY 2018.

Revenue · FY 2018
₹61.67 Cr ▲ 74%
Net profit · FY 2018
₹6.4 Cr margin 10.4%
EBITDA · FY 2018
₹10.11 Cr margin 16.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 191%
EBITDA CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 175%

Revenue has grown at a compounded annual rate (CAGR) of 191% over three years, including 74% growth in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.11 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.4 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin16.4%
Net Profit Margin10.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of DNV Overseas Impex Private Limited, buy the company report.

Board of directors of DNV Overseas Impex Private Limited

DNV Overseas Impex has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Deepak MalhotraDirector27 Dec 200817 Years 10 MonthsAs last reported
Abhiruchi MengiDirector08 Dec 201411 Years 11 MonthsAs last reported
Madhu AhujaDirector08 Dec 201411 Years 11 MonthsAs last reported

Peer comparison

DNV Overseas Impex Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shamshree Lifesciences Limited₹62.27 Cr (FY 2025)10.0%Chandigarh, India
Cian Healthcare Limited₹62.14 Cr (FY 2024)-10.0%Pune, Maharashtra, India
Enanti Labs Private Limited₹62.07 Cr (FY 2025)-14.0%Hyderabad, Telangana, India
MDC Pharmaceuticals Limited₹61.89 Cr (FY 2024)14.0%Chandigarh, India
DNV Overseas Impex Private Limitedthis company₹61.67 Cr (FY 2018)₹6.4 Cr10.4%74.0%New Delhi, Delhi, India
Unijules Life Sciences Limited₹61.64 Cr (FY 2018)-4.0%Nagpur, Maharashtra, India
Revat Laboratories Private Limited₹61.45 Cr (FY 2025)10.0%Hyderabad, Telangana, India
Gelnova Laboratories (India) Private Limited₹61.38 Cr (FY 2025)-4.0%Navi Mumbai, Maharashtra, India
Mistair Health and Hygiene Private Limited₹61.27 Cr (FY 2025)-21.0%Mumbai, Maharashtra, India

To see the full peer comparison of DNV Overseas Impex Private Limited, buy the company report.

Auditor

DNV Overseas Impex Private Limited is audited by M MITTAL & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
M MITTAL & COFY 2017003550N

Shareholding

The shareholding of DNV Overseas Impex Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of DNV Overseas Impex Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹7.09 Cr
Breakdown by lending institutions
Andhra Bank₹7.09 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Jan 201410476816Andhra Bank₹1.63 CrSatisfied
17 Apr 200910157365Andhra Bank₹5.47 CrSatisfied

To see the full charge records of DNV Overseas Impex Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

DNV Overseas Impex Private Limited has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.48 Cr; the latest was in November 2017.

Total deals
10
Secondary share transfers
7
Funding rounds
3
Disclosed funding
₹4.48 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Apr 2010Secondary share transferUndisclosedBuyer: Rhythm Music Technology Private Limited
Seller: Nishad Consultant Private Limited, 3 individuals
Mar 2010Funding round₹2.06 CrInvestors: Nishad Consultant Private Limited, 3 individuals
Sep 2009Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Godawari Buildcon Private Limited , Natma Securities Private Limited , 2 individuals
Mar 2008Funding round₹1.7 CrInvestors: Godawari Buildcon Private Limited , Natma Securities Private Limited , Rhythm Music Technology Private Limited
Mar 2008Secondary share transferUndisclosedBuyer: 3 individuals
Seller: Shubh Lakshmi Capital Limited , Sapna Cans Private Limited , Navdeep Portfolio Private Limited

To see the full deal history of DNV Overseas Impex Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for DNV Overseas Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

DNV Overseas Impex has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of DNV Overseas Impex Private Limited, buy the company report.

Recent activity

DNV Overseas Impex Private Limited has 10 board changes on record since 2008: 3 appointments and 7 cessations. The latest: Abhiruchi Mengi ceased to be Additional Director on 30 Sep 2015.

AGM
Dnv Overseas Impex Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
Charges
A charge registered on 01 Jan 2014 via Charge ID 10476816 with Andhra Bank was fully satisfied on 13 Jul 2018.
Charges
A charge registered on 17 Apr 2009 via Charge ID 10157365 with Andhra Bank was fully satisfied on 13 Jul 2018.
Filing
Dnv Overseas Impex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi.
Ceased
Abhiruchi Mengi ceased to be Additional Director.
Ceased
Madhu Ahuja ceased to be Additional Director.
Ceased
Naresh Kumar Malhotra ceased to be Director.
Ceased
Vijay Malhotra ceased to be Director.
Appointed
Abhiruchi Mengi was appointed as Director.
Appointed
Madhu Ahuja was appointed as Director.
Charges
A charge with Andhra Bank amounted to Rs. 1.63 Cr with Charge ID 10476816 was registered on 01 Jan 2014.
Charges
A charge with Andhra Bank of Rs. 5.47 Cr registered on 17 Apr 2009 with Charge ID 10157365 was modified on 12 Oct 2012.

6 earlier events are in the company report.

Frequently asked questions

DNV Overseas Impex has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

DNV Overseas Impex was a private limited company based in New Delhi, Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 23 September 2004 and is registered under CIN U51909DL2004PTC129354. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

DNV Overseas Impex was incorporated on 23 September 2004. It is registered with the Registrar of Companies, Delhi.

DNV Overseas Impex had 3 directors:

The CIN (Corporate Identification Number) of DNV Overseas Impex is U51909DL2004PTC129354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of DNV Overseas Impex is at Tf – 1 Ansal Utility Commercial Complex Paschim Vihar, New Delhi, Delhi, India – 110063.

DNV Overseas Impex can be reached through the website dnvoverseas.com. Its registered office is in New Delhi, Delhi, India.

The latest financial statements of DNV Overseas Impex on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.

No. DNV Overseas Impex has 2 GST registrations on record and all of them are cancelled or inactive.

DNV Overseas Impex operated in the pharma industry, in the drug formulation and development segment.

DNV Overseas Impex has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹4.48 Cr; the latest was in November 2017.